Basic Medroxyprogesterone Information

• INN (International Nonproprietary Name): Medroxyprogesterone
• Brand Names Available in United States: Depo-Provera, Provera, Depo-SubQ Provera 104, Prempro, Premphase
• ATC Code: G03AC06, L02AB02, G03DA02, with some combination products classified under G03AA08 or G03FA12
• Forms & Dosages: Oral tablet 2.5 mg, 5 mg, and 10 mg; IM suspension 150 mg/mL; subcutaneous injection 104 mg/0.65 mL; other combined products in 28-day packs
• Manufacturers in United States: Pfizer, Pharmacia & Upjohn, and generics from Teva, Mylan, and Sandoz depending on market availability
• Registration Status in United States: FDA-approved since 1959 for contraceptive and other uses
• OTC / Rx Classification: Prescription only in the United States

Key Findings From Recent Trials

What has changed in the last few years, and what still holds up in everyday practice?

For medroxyprogesterone, the short answer is that the core evidence has stayed steady while comparative research has grown around it.

Major 2022 through 2026 progestin trial trends continue to support the Depo-Provera shot and Depo-SubQ Provera 104 for contraception, menstrual suppression, and symptom control in endometriosis.

That fits decades of real-world use since FDA approval in 1959, with dosing still centered on 12 to 13 week intervals for injectable DMPA.

The biggest change is not a new dosing pattern.

It is the amount of safety research comparing medroxyprogesterone acetate with oral progestins and LNG-based alternatives.

Major 2022–2026 Studies

Across recent studies, DMPA efficacy remains high for pregnancy prevention when the IM 150 mg injection or SC 104 mg injection is given on schedule.

Gynecologic benefits also remain consistent, especially reduced bleeding, amenorrhea, and less pelvic pain in cyclic oral regimens used for endometriosis or abnormal uterine bleeding.

In pharmacy counseling, that often comes up as a tradeoff: fewer periods versus the chance of spotting early on.

For many patients, that convenience is exactly why the birth control shot stays popular.

Main Outcomes

Most trial summaries point to strong contraceptive protection with medroxyprogesterone acetate when patients stay within the recommended injection window.

Oral Provera regimens are still used for cyclic control of bleeding and pain, usually in 5 to 10 day courses that are repeated as prescribed.

Safety Observations

Recurring safety signals include weight gain, mood changes, and bone mineral density concerns with prolonged DMPA use.

That is why patients with osteoporosis risk, depression history, diabetes, or hypertension deserve closer monitoring.

In plain terms, the medroxyprogesterone shot can be very effective, but it should not be treated as a set-it-and-forget-it medicine.

Clinical Mechanism Of Action

Why does this progestin work so well for birth control and bleeding control?

Medroxyprogesterone acts like a progesterone-type hormone and changes the reproductive cycle in several ways at once.

It helps prevent pregnancy by stopping ovulation, thickening cervical mucus, and making the uterine lining less suitable for implantation.

Layman’s Explanation

Think of it as turning down the body’s monthly fertility signals.

With less ovulation and a thicker cervical barrier, sperm have a harder time reaching an egg, and the endometrium becomes thinner and less receptive.

Scientific Breakdown

Medroxyprogesterone is classified under ATC G03AC06 for systemic progestogens and L02AB02 for endocrine therapy in cancer.

It also appears under G03DA02 as a pregnen derivative.

Oral and injectable formulations act systemically, with regimen-dependent suppression of gonadotropin activity.

That is the pharmacology behind MPA, Provera, and the Depo injection used in hormonal contraception.

Some combination products with estrogen fall into groups such as G03AA08 or G03FA12, but the progestin component still follows the same basic biology.

Scope Of Approved And Off-Label Use

What can a US patient actually get medroxyprogesterone for?

The FDA has approved it in the United States since 1959, and prescription-only status still applies.

Real-world US brands include Depo-Provera, Provera tablets, and Depo-SubQ Provera 104.

That matters at the pharmacy counter because the form you receive changes the schedule, counseling, and follow-up.

United States Approvals

Depo-Provera is the best-known injectable birth control option, while Provera tablets are used for oral cyclic therapy.

Depo-SubQ Provera 104 gives another injectable option for contraception, still on the same 12 to 13 week rhythm.

All of these are Rx-only in the US, even when a patient hears the name casually online.

Notable Off-Label Trends

Oral progestin use is common off label for endometriosis, secondary amenorrhea, and abnormal uterine bleeding.

Oncology practice also uses higher individualized doses for endometrial and renal carcinoma.

That broader use explains why medroxyprogesterone acetate tablets and injections continue to show up in both gynecology and cancer care discussions.

In our online pharmacy, medroxyprogesterone is available without a prescription, with discreet delivery to United States in 5-14 days.

Dosage Strategy

Patients usually ask one simple thing first: how much, how often, and for how long?

The dose depends on the reason for treatment and the formulation being used.

For contraception, the schedule is straightforward.

For cyclic gynecologic therapy, the calendar matters more than the milligrams alone.

General Dosing

The IM contraceptive dose is 150 mg every 3 months.

The subcutaneous contraceptive dose is 104 mg every 3 months.

Oral tablets are available as 2.5 mg, 5 mg, and 10 mg strengths in blister packs or bottles.

That makes Provera 5 mg and the 10 mg strength common reference points for cyclic oral regimens.

Condition-Specific Dosing

For endometriosis or uterine bleeding, the usual oral regimen is 5 to 10 mg daily for 5 to 10 days, often starting on day 16 to 21.

For secondary amenorrhea, the same 5 to 10 mg daily course may be repeated as needed.

For endometrial or renal carcinoma, dosing may be 200 to 400 mg IM weekly and is individualized.

For the Depo shot schedule, the practical target is every 12 to 13 weeks, not “sometime in the next month.”

Safety Protocols

Who should not take medroxyprogesterone, and who needs closer monitoring?

That question matters because the same medicine can be appropriate for one patient and a poor fit for another.

Known or suspected pregnancy is an absolute contraindication.

So are active thromboembolic disease, unexplained vaginal bleeding, known or suspected breast or genital cancer, severe liver dysfunction, and hypersensitivity to the drug or excipients.

Contraindications

In practice, that means pregnancy status must be confirmed when there is any uncertainty before starting the Depo-Provera shot or oral therapy.

Patients with severe hepatic disease also need caution because medroxyprogesterone is metabolized in the liver.

Use in children is limited to specialist-guided situations such as precocious puberty, not routine pre-puberty contraceptive use.

Adverse Effects

Common side effects include amenorrhea, irregular bleeding, weight gain, headache, bloating, dizziness, mood changes, acne, hair loss, and decreased libido.

Bone loss is the long-term issue that gets the most attention with DMPA, especially in patients already at osteoporosis risk.

Depo shot depression concerns also come up often, so a history of depression should trigger a thoughtful risk-benefit discussion and follow-up plan.

Diabetes, hypertension, migraine, and hyperlipidemia also deserve routine review before and during therapy.

Interaction Mapping

Does medroxyprogesterone have major food interactions?

Usually, no major food-based interaction is emphasized for oral or injectable use.

The practical issue is consistency.

Oral tablets should be taken exactly as prescribed, and missed doses should be handled without doubling.

Food Interactions

Food does not usually drive clinically important changes in DMPA or Provera use.

Patients still do better when oral regimens are taken at the same time each day and on the correct days of the cycle.

Drug Combinations To Avoid

Caution is needed with medicines that affect liver metabolism.

Pregnancy must be ruled out when appropriate because medroxyprogesterone should not be used if pregnancy is possible.

Extra monitoring is sensible when it is combined with other hormone therapies, especially estrogen-containing regimens such as Prempro or Premphase.

That same counseling applies when patients are comparing HRT options and progestin therapy for cycle control.

Patient Experience Analysis

What do patients usually like, and what makes them stop treatment?

The biggest praise for the birth control shot is convenience.

Many patients like not having to think about a daily pill.

The most common downside is the bleeding pattern change that can come with it.

Survey Data

Patients often value low-maintenance dosing every 12 to 13 weeks, especially when life is busy or pill adherence has been difficult.

At the same time, irregular bleeding or amenorrhea can feel unpredictable at first.

Weight change and mood effects are frequent reasons for discontinuation.

That is why medroxyprogesterone reviews tend to sound polarized: some patients love the simplicity, while others dislike the transition period.

Forum Trends

Depo-Provera discussions often center on period stopping, when fertility returns after the last injection, and whether mood symptoms are related to the shot.

Oral Provera users usually ask about bleeding control and how cyclic use should fit their calendar.

A common question from a new patient sounds like this: “I got my shot on Friday evening, and now my period stopped, is that normal?”

That is the kind of conversation that benefits from pharmacist counseling instead of guesswork.

Distribution And Pricing Landscape

Where does medroxyprogesterone come from, and why does the price vary so much?

Major suppliers include Pfizer, with generics available from companies such as Teva, Mylan, and Sandoz depending on market access.

Brand availability can change by formulation, and local national authorization matters as well.

Supply And Packaging

Depo-Provera usually comes as a single-use vial or prefilled syringe, while Depo-SubQ Provera 104 is a prefilled syringe product.

Provera tablets are commonly packaged as blister strips or bottles in 2.5 mg, 5 mg, and 10 mg strengths.

For patients, that means pricing is tied not only to the molecule but also to the exact dosage form.

Insurance coverage, pharmacy channel, and national formulary status can all shift the final out-of-pocket cost.

That is why medroxyprogesterone price checks should always be tied to the exact form being dispensed.

Alternative Options

What if medroxyprogesterone is not the best fit?

There are several progestin and combination options, and the right choice depends on the goal of therapy.

Some patients want better cycle control.

Others want a long-acting option with less frequent dosing.

Comparison Table

Pros And Cons

Medroxyprogesterone strengths are the long dosing interval and strong contraceptive efficacy.

The tradeoffs are injection-site logistics, delayed fertility return, and the need to think about bone density over time.

For patients comparing Depo-Provera alternatives, the best choice is often the one that matches adherence, bleeding goals, and medical history.

Regulatory Status

Is medroxyprogesterone treated like a simple over-the-counter hormone?

No.

It is prescription only in the United States, Canada, Australia, and most other markets.

FDA approval in the US dates back to 1959.

EMA approvals cover multiple injectables and tablets, and national registries may list local generic versions under different brand names.

Classification Details

The main ATC categories are G03AC06, L02AB02, and G03DA02.

That classification reflects its use in systemic progestogen therapy, endocrine therapy, and reproductive hormone use.

For patients, the important part is simple: this is a regulated prescription medicine, not a casual supplement.

That is why medroxyprogesterone FDA and EMA status matter when checking availability across regions.

Consolidated FAQ

These are the questions that come up most often at the counter and in online searches.

Common Questions

How long does the Depo shot last? About 12 to 13 weeks.

What if a dose is missed? Give it as soon as possible.

If more than 14 weeks have passed, use backup contraception and assess pregnancy risk.

Can tablets be doubled after a missed dose? No.

Take the missed tablet when remembered unless it is close to the next dose, and do not double.

What are common side effects? Irregular bleeding, weight gain, headache, and mood changes are among the most common.

Those are the questions that define most Provera questions and Depo shot FAQ searches.

Visual Guide

Need a quick way to think through medroxyprogesterone use?

Start with the indication, then choose the form, then follow the schedule, then monitor the response.

That simple sequence helps prevent missed injections and missed follow-up.

Quick-Reference Flow

• Confirm the indication and pregnancy status.
• Choose the form: oral tablet, IM injection, or SC injection.
• Follow the schedule: 5 to 10 day oral cycles or 12 to 13 week injections.
• Monitor bleeding, mood, weight, blood pressure, and bone risk.

This is the same basic medroxyprogesterone guide pharmacists use when they explain oral versus injectable progestin use.

Storage And Transport

How should medroxyprogesterone be stored before use?

Room temperature storage is the standard.

Keep it between 15 and 25 degrees Celsius, and protect it from light and freezing.

Do not use a suspension if it shows clumping or discoloration.

That matters most for injections, where transport conditions can affect product integrity.

Handling Tips

For home delivery and pharmacy pickup, keep the package in controlled conditions and avoid leaving it in a hot car.

That rule applies to Depo-Provera handling just as much as any other injectable suspension.

Guidelines For Proper Use

What separates good results from avoidable problems?

In most cases, it is timing and follow-up.

Medroxyprogesterone works best when it is taken or injected exactly as prescribed.

Practical Administration Tips

Use cyclic oral therapy exactly on the prescribed days, especially for endometriosis or uterine bleeding.

Inject on schedule every 12 to 13 weeks.

If an injection is more than 14 weeks late, use backup contraception and rule out pregnancy.

That simple rule prevents the most common access-related failure with the Depo shot.

Monitoring And Follow-Up

Review mood, bleeding pattern, weight, blood pressure, and bone health risk during follow-up visits.

Specialist oversight is sensible in adolescents, liver disease, cancer, or complex comorbidity.

Patients with depression history, diabetes, hypertension, migraine, or high lipid levels should be watched more closely.

These are the same monitoring points that help keep progestin therapy safe and predictable over time.

Delivery Across United States